Research location
Sherbrooke
Canada
Advertisement
Research activity in Sherbrooke
CanadaCureCurrent currently publishes aggregate city-level research activity for this location: 60 trials and 61 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Sherbrooke
60 linked trials · page 1 of 2A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)NCT07759245 · 2026-08-07 · 1 site observation
RECRUITING
A Study of Brenipatide in Adult Participants With Major Depressive DisorderNCT07412756 · 2026-02-09 · 1 site observation
RECRUITING
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseNCT07181109 · 2025-09-22 · 2 site observations
RECRUITING
Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult CareNCT05910840 · 2024-10-07 · 1 site observation
RECRUITING
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)NCT05485961 · 2024-04-27 · 1 site observation
RECRUITING
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or ObesityNCT07861100 · 2026-10-26 · 1 site observation
NOT_YET_RECRUITING
A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or OverweightNCT07357415 · 2026-01-24 · 1 site observation
ACTIVE_NOT_RECRUITING
A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or OverweightNCT06962280 · 2025-05-12 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)NCT06653153 · 2024-10-24 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)NCT06215911 · 2024-02-13 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesNCT05536804 · 2023-02-08 · 1 site observation
COMPLETED
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of InflammationNCT05318976 · 2022-02-28 · 1 site observation
COMPLETED
Screening for Occult Malignancy in Patients With Unprovoked Venous ThromboembolismNCT04304651 · 2020-09-08 · 1 site observation
ACTIVE_NOT_RECRUITING
Tai Chi Intervention by TelerehabilitationNCT03985631 · 2020-01-22 · 1 site observation
COMPLETED
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast CancerNCT03901339 · 2019-05-08 · 1 site observation
COMPLETED
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following SurgeryNCT03809000 · 2019-04-15 · 1 site observation
ACTIVE_NOT_RECRUITING
Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBCNCT03858972 · 2019-02-05 · 1 site observation
TERMINATED
Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)NCT03521934 · 2018-06-15 · 1 site observation
TERMINATED
Effect of Efpeglenatide on Cardiovascular OutcomesNCT03496298 · 2018-04-27 · 1 site observation
TERMINATED
Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With MetforminNCT03351478 · 2017-11-27 · 1 site observation
COMPLETED
A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes MellitusNCT02973321 · 2016-12-02 · 1 site observation
COMPLETED
Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic TherapyNCT02926937 · 2016-11-11 · 1 site observation
COMPLETED
Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of MetforminNCT02926950 · 2016-11-01 · 1 site observation
COMPLETED
A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's DiseaseNCT02760602 · 2016-06-01 · 1 site observation
TERMINATED
Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes MellitusNCT02735044 · 2016-04-14 · 1 site observation
COMPLETED
Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1NCT02660138 · 2016-03-01 · 1 site observation
TERMINATED
Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)NCT02414854 · 2015-04-27 · 1 site observation
COMPLETED
Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus PatientsNCT02401243 · 2015-03-01 · 1 site observation
COMPLETED
Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate CancerNCT03761225 · 2014-09-01 · 1 site observation
COMPLETED
Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)NCT02134028 · 2014-08-05 · 1 site observation
COMPLETED
A Study of LY2623091 in Participants With High Blood PressureNCT02194465 · 2014-08-01 · 1 site observation
COMPLETED
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With DonepezilNCT02006641 · 2014-02-01 · 1 site observation
COMPLETED
MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint PacingNCT02006069 · 2013-12-01 · 1 site observation
TERMINATED
Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic PatientsNCT01798706 · 2013-06-01 · 1 site observation
COMPLETED
Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic PatientsNCT01768559 · 2013-01-01 · 1 site observation
COMPLETED
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic TherapyNCT01676220 · 2012-08-01 · 1 site observation
COMPLETED
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic TherapyNCT01499095 · 2011-12-01 · 1 site observation
COMPLETED
Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)NCT01360866 · 2011-10-01 · 1 site observation
COMPLETED
Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on DonepezilNCT01266525 · 2011-02-01 · 1 site observation
COMPLETED
Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-betaNCT01252355 · 2011-01-01 · 1 site observation
TERMINATED
Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS)NCT01199861 · 2010-08-01 · 1 site observation
COMPLETED
A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive DisorderNCT01034995 · 2010-02-01 · 1 site observation
COMPLETED
Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 DiabetesNCT01029886 · 2010-01-01 · 1 site observation
COMPLETED
Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's DiseaseNCT01019421 · 2009-12-01 · 1 site observation
COMPLETED
Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary DiseaseNCT00877383 · 2009-04-01 · 1 site observation
COMPLETED
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of PioglitazoneNCT00763815 · 2008-09-01 · 1 site observation
COMPLETED
Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)NCT00677807 · 2008-05-01 · 1 site observation
COMPLETED
ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung CancerNCT00662597 · 2008-04-01 · 1 site observation
TERMINATED
Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple SclerosisNCT00622700 · 2008-02-01 · 1 site observation
COMPLETED
Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the BreastNCT00470236 · 2007-06-01 · 1 site observation
UNKNOWN
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.